Ozempic has delivered impressive results for millions of Americans, but not everyone can stomach the cost of popular weight loss drugs. Depending on a patient’s location, insurance coverage and dosage ...

Dr. Angela Fitch, co-founder and chief medical officer of knownwell, a "weight-inclusive" healthcare company based in Boston, said she would caution against labeling any medication as an "everything ...

The US Food and Drug Administration (FDA) has instructed all GLP-1 drug-makers to update their warning labels to include the risk of serious kidney injury that can result from dehydration. This comes ...

The explosive rise of GLP-1 medications—such as Mounjaro, Ozempic, and Wegovy—has ignited more than just headlines. It has fundamentally shifted how Americans access and pay for medications, driving ...

Recent research has shown how weight-loss and diabetes medications, also known as glucagon-like peptide-1 receptor agonists (GLP-1s), can help with a variety of other conditions. This includes ...

People who stopped taking GLP-1s regained weight within two months. People who stop taking GLP-1 medications like Wegovy and Zepbound started to regain weight in a short amount of time, a new study ...

A new report based on national prescription data shows weight-loss drug use is rising among kids and teens. GLP-1 medications, like Ozempic and Wegovy, are drugs originally developed to treat diabetes ...

Before beginning any new exercise program, consult your doctor. Stop immediately if you experience pain. More than 15 million Americans are now losing weight with GLP-1 drugs. The medications — drugs ...

Welcome to Culture Clinic, MedPage Today's collaboration with Northwell Health to offer a healthcare professional's take on the latest viral medical topics. Doctors performing certain medical scans on ...

Among nearly 10,000 GLP-1 receptor agonist prescriptions given at a single health system, 60% were filled. Fill rates varied by patient race and ethnicity, as well as indication. Researchers suggested ...